Home > Adam's Blog > Heart Valve Replacement > Epic Plus Tissue Valve Gets FDA Approval for Lifetime Management of Heart Valve Disease

Epic Plus Tissue Valve Gets FDA Approval for Lifetime Management of Heart Valve Disease

Written By: Adam Pick, Patient Advocate, Author & Website Founder
Published: May 31, 2022

Hey everybody,

In case you missed it… I just posted a new article and video about the recent FDA approval of the Epic Plus tissue heart valve replacement that does not require anti-coagulant therapy. In the post, Dr. Kenith Fang, Chief of Cardiothoracic Surgery at Banner University Medical Center Phoenix, answers several important questions about the unique technologies in the Epic Plus that are designed to help patients manage heart valve disease throughout their lifetime.

To learn about the new Epic Plus heart valve, click here.

So you know, the original Epic valve first came out in 2008. So far, that valve has been implanted in over 250,000 patients around the world.

The new Epic “Plus” valve offers patients several new innovations for valve-in-valve procedures and enhanced durability that you can learn about at this link.

Keep on tickin!
Adam

Written by Adam Pick
- Patient & Website Founder

Written by Adam Pick - Patient & Website Founder

Adam Pick is a heart valve patient and author of The Patient's Guide To Heart Valve Surgery. In 2006, Adam founded HeartValveSurgery.com to educate and empower patients. This award-winning website has helped over 10 million people fight heart valve disease. Adam has been featured by the American Heart Association and Medical News Today.